Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WMfor Waldenstrom MacroglobulinemiaDrug: Rituximab5 locations incl. DenverSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06561347·Phase 2·RecruitingApply to this trial
GpCRC Pediatric Gastroparesis Registry 2for Gastroparesis6 locations incl. BostonSponsor: Johns Hopkins Bloomberg School of Public HealthSex: All·Age: 8 - 25Code: NCT05981300·RecruitingApply to this trial
Family Members At INcreased-risk for Developing Inflammatory Bowel Diseasefor Inflammatory Bowel Disease (IBD)1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 14+·Accepts healthy volunteersCode: NCT06655415·RecruitingApply to this trial
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanomafor Metastatic Uveal MelanomaDrug: Nivolumab29 locations incl. ScottsdaleSponsor: Replimune, Inc.Sex: All·Age: All agesCode: NCT06581406·Phase 2, Phase 3·RecruitingApply to this trial
Physiology of Human Brain Connectivityfor Healthy1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18 - 64·Accepts healthy volunteersCode: NCT06246942·RecruitingApply to this trial
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failurefor Heart Failure57 locations incl. PhoenixSponsor: Abbott Medical DevicesSex: All·Age: 18+Code: NCT06526195·RecruitingApply to this trial
Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumorsfor Advanced or Metastatic Solid Tumors2 locations incl. BostonSponsor: Hanmi Pharmaceutical Company LimitedSex: All·Age: 18+Code: NCT06724016·Phase 1·RecruitingApply to this trial
Testing the mHealth App Intervention for Nondaily Smokers "SiS4"for Smoking Cessation1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06678243·RecruitingApply to this trial
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1for Neurofibromatosis 11 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: All agesCode: NCT06262113·RecruitingApply to this trial
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutationfor Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)9 locations incl. DenverSponsor: Institut de Recherches Internationales ServierSex: All·Age: 18+Code: NCT06465953·Phase 3·RecruitingApply to this trial
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalusfor Normal Pressure Hydrocephalus28 locations incl. Los AngelesSponsor: CereVasc IncSex: All·Age: 60+Code: NCT06498960·RecruitingApply to this trial
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumoursfor Advanced Solid Tumor5 locations incl. RogersSponsor: Adcendo ApSSex: All·Age: 18+Code: NCT06597721·Phase 1·RecruitingApply to this trial
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Carefor Eosinophilic Esophagitis (EoE)54 locations incl. PhoenixSponsor: Regeneron PharmaceuticalsSex: All·Age: 1+Code: NCT06693531·RecruitingApply to this trial
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.for Epithelial Ovarian Cancer26 locations incl. PhoenixSponsor: TORL Biotherapeutics, LLCSex: Female·Age: 18+Code: NCT06690775·Phase 2·RecruitingApply to this trial
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancerfor Hormone Receptor Positive HER-2 Negative Breast Cancer35 locations incl. BirminghamSponsor: Puma Biotechnology, Inc.Sex: All·Age: 18+Code: NCT06369285·Phase 2·RecruitingApply to this trial
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AMLfor Leukemia53 locations incl. GoodyearSponsor: Daiichi SankyoSex: All·Age: 18 - 70Code: NCT06578247·Phase 3·RecruitingApply to this trial
REcovery From DEXmedetomidine-induced Unconsciousnessfor Anesthesia1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18 - 65·Accepts healthy volunteersCode: NCT06003127·RecruitingApply to this trial
Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorderfor Neuromyelitis Optica Spectrum Disorder2 locations incl. AtlantaSponsor: MedRhythms, Inc.Sex: All·Age: 18 - 70Code: NCT06374264·Enrolling By Invitation
Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvisfor Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring12 locations incl. PhoenixSponsor: University of Southern CaliforniaSex: All·Age: 60+Code: NCT06496867·RecruitingApply to this trial
Measuring Brain Complexity to Detect and Predict Recovery of Consciousness in the ICUfor Consciousness Disorders2 locations incl. BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06568536·RecruitingApply to this trial
Efficacy and Safety of Leadless Pacemakers Versus Left Bundle Area Pacing - A Preliminary Explorationfor Pacemaker Implantation2 locations incl. NaplesSponsor: NCH Healthcare System, Inc. dba Naples Comprehensive Health and dba NCHSex: All·Age: 18+Code: NCT06690333·RecruitingApply to this trial
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfafor Myasthenia Gravis17 locations incl. San FranciscoSponsor: argenxSex: All·Age: 18+Code: NCT06298565·RecruitingApply to this trial
Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Studyfor Chronic Subdural Hematoma31 locations incl. PhoenixSponsor: The University of Texas Medical Branch, GalvestonSex: All·Age: 40 - 90Code: NCT06347796·RecruitingApply to this trial
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumorsfor Solid Tumor, Adult19 locations incl. DuarteSponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Sex: All·Age: 18+Code: NCT06625775·Phase 1·RecruitingApply to this trial
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failurefor Cardiovascular Diseases37 locations incl. Little RockSponsor: BrioHealth Solutions, Inc.Sex: All·Age: 18 - 100Code: NCT06310031·RecruitingApply to this trial
Psychoeducational Intervention for Patients With Hepatocellular Carcinomafor Hepatocellular Carcinoma1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06541990·RecruitingApply to this trial
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)for Primary Myelofibrosis13 locations incl. Palo AltoSponsor: Ajax Therapeutics, Inc.Sex: All·Age: 18+Code: NCT06343805·Phase 1·RecruitingApply to this trial
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)for Carcinoma, Non-Small-Cell LungDrug: Intismeran autogene48 locations incl. GilbertSponsor: Merck Sharp & Dohme LLCSex: All·Age: 18+Code: NCT06623422·Phase 3·RecruitingApply to this trial
THRIVE-CAR-T Digital Appfor CAR T-Cell Therapy1 location in BostonSponsor: Patrick C. Johnson, MDSex: All·Age: 18+Code: NCT06665295·RecruitingApply to this trial
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancersfor Pancreatic Ductal Adenocarcinoma10 locations incl. BirminghamSponsor: Novartis PharmaceuticalsSex: All·Age: 18 - 100Code: NCT06562192·Phase 1·RecruitingApply to this trial
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophyfor Familial Partial Lipodystrophy7 locations incl. BirminghamSponsor: Amryt PharmaSex: All·Age: 13+Code: NCT06679270·Phase 3·RecruitingApply to this trial
The CurePSP Genetics Programfor PSP1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 35+·Accepts healthy volunteersCode: NCT06647641·RecruitingApply to this trial
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minoritiesfor Coronary Artery Disease18 locations incl. GlendaleSponsor: Weill Medical College of Cornell UniversitySex: All·Age: 18+Code: NCT06399705·Phase 3·RecruitingApply to this trial
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphomafor Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedDrug: Soquelitinib21 locations incl. DuarteSponsor: Corvus Pharmaceuticals, Inc.Sex: All·Age: 18+Code: NCT06561048·Phase 3·RecruitingApply to this trial
Improving Health for Older Adults With Pain Through Engagementfor Chronic Pain1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 55+Code: NCT06119698·RecruitingApply to this trial
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2for Food Insecurity1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18 - 90·Accepts healthy volunteersCode: NCT06298253·RecruitingApply to this trial
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrencefor Breast Cancer165 locations incl. DaphneSponsor: Stemline Therapeutics, Inc.Sex: All·Age: 18+Code: NCT06492616·Phase 3·RecruitingApply to this trial
Bionic Pancreas in CFRDfor Cystic Fibrosis-related Diabetes16 locations incl. AuroraSponsor: Jaeb Center for Health ResearchSex: All·Age: 14+Code: NCT06449677·Phase 3·RecruitingApply to this trial
Gastroparesis Registry 4for Gastroparesis6 locations incl. ScottsdaleSponsor: Johns Hopkins Bloomberg School of Public HealthSex: All·Age: 18 - 85Code: NCT05846802·RecruitingApply to this trial
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumorsfor Metastatic Solid Tumor17 locations incl. Santa MonicaSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT06561685·Phase 1·RecruitingApply to this trial